scholarly journals Temporal Lobe Epilepsy as a Unique Manifestation of Multiple Sclerosis

Author(s):  
Antonio Gambardella ◽  
Paola Valentino ◽  
Angelo Labate ◽  
Grazia Sibilia ◽  
Francesca Ruscica ◽  
...  

Objective:To report on five patients with temporal lobe epilepsy (TLE) as the unique manifestation of multiple sclerosis (MS).Methods:Among 350 consecutive MS patients, we identified 16/350 (4.6%) who also had epileptic seizures. Here, we review their electrophysiological and clinical features.Results:Five of these 16 patients (four female, one male; mean age 34.2 years; range 31 to 38) with MS and epileptic seizures had an extremely homogeneous clinical picture characterized by TLE as the unique manifestation of MS, even at long follow-up (mean: five years; range 4 to 10). In all patients, seizures started in the second or third decade. Brain MRI revealed at least one juxta-cortical lesion within the temporal region. Antiepileptic medication was always effective.Conclusions:The present study provides the first evidence of a peculiar form of MS characterized by TLE as the unique manifestation of the disease with no disability or MS relapses at long-term follow-up.

Epilepsia ◽  
2010 ◽  
Vol 51 (6) ◽  
pp. 1024-1029 ◽  
Author(s):  
Michael Murphy ◽  
Paul D. Smith ◽  
Martin Wood ◽  
Stephen Bowden ◽  
Terence J. O’Brien ◽  
...  

Healthcare ◽  
2021 ◽  
Vol 9 (9) ◽  
pp. 1156
Author(s):  
Ioanna Alexandratou ◽  
Panayiotis Patrikelis ◽  
Lambros Messinis ◽  
Athanasia Alexoudi ◽  
Anastasia Verentzioti ◽  
...  

We present an update of the literature concerning long-term neuropsychological outcomes following surgery for refractory temporal lobe epilepsy (TLE). A thorough search was conducted through the PubMed and Medline electronic databases for studies investigating neuropsychological function in adult patients undergoing resective TLE surgery and followed for a mean/median > five years period. Two independent reviewers screened citations for eligibility and assessed relevant studies for the risk of bias. We found eleven studies fulfilling the above requirements. Cognitive function remained stable through long-term follow up despite immediate post-surgery decline; a negative relation between seizure control and memory impairment has emerged and a possible role of more selective surgery procedures is highlighted.


2007 ◽  
Vol 13 (4) ◽  
pp. 502-508 ◽  
Author(s):  
M. Rovaris ◽  
G. Comi ◽  
MA Rocca ◽  
P. Valsasina ◽  
D. Ladkani ◽  
...  

Glatiramer acetate (GA) is effective in reducing clinical and magnetic resonance imaging (MRI) activity in relapsing-remitting multiple sclerosis (RRMS). Serial long-term MRI data are lacking for large cohorts of GA-treated patients. The European/Canadian GA study consisted of two consecutive phases, each lasting nine months. The first treatment phase was randomized, double-blind and placebo-controlled. The second was an open-label, active treatment phase with daily administration of 20 mg GA subcutaneously for all patients. For the long-term follow-up (LTFU), dual echo, pre- and postgadolinium T1-weighted brain MRI scans were obtained with the same acquisition scheme as for the original trial and a neurological assessment was performed. Lesion volumes, normalized brain volumes and percentage brain volume changes (PBVC) were measured. One hundred and forty-two (63.4%) of the 224 patients who completed the two phases of the European/Canadian study underwent the LTFU after a mean period of 5.8 years (range: 5.3-6.4); 73 were treated with GA from study initiation. MRI measures at LTFU did not significantly differ between patients originally assigned to placebo and those who were always treated with GA, but the proportion of patients who did not require walking aids at LTFU was lower in the latter group (P=0.034). PBVC between baseline and LTFU was significantly correlated with lesion load at study entry. An earlier initiation of GA treatment in patients with active RRMS might, at least partially, have a favourable impact on long-term disease evolution. Multiple Sclerosis 2007; 13: 502-508. http://msj.sagepub.com


1982 ◽  
Vol 36 (3) ◽  
pp. 263-265
Author(s):  
Hirotsune Kawamura ◽  
Keiichi Amano ◽  
Tatsuya Tanikawa ◽  
Hiroko Kawabatake ◽  
Masao Notani ◽  
...  

2008 ◽  
Vol 14 (3) ◽  
pp. 111-113 ◽  
Author(s):  
Márcia E. Morita ◽  
Lívia Conz ◽  
Claudia V. Maurer-Morelli ◽  
Eliane Kobayashi ◽  
Clarissa L. Yasuda ◽  
...  

OBJECTIVE: To analyze seizure outcome in individuals with familial mesial temporal lobe epilepsy (FMTLE). METHOD: We followed prospectively 64 individuals with FMTLE and 37 asymptomatic individuals belonging to 28 families. RESULTS: Patients with FMTLE had a mean follow up was 93.4 ± 15.8 months. At baseline they were divided in benign (n = 29), remission (n = 28) and refractory (n = 7). At last follow up visit 41.4% patients with benign FMTLE remained classified as benign, 20.7% became refractory and 37.9% were in remission. In the subgroup of FMTLE in remission 21 75% remained without seizures; 21.4% were classified as benign FMTLE, and one died (3.6%) from cause unrelated to epilepsy. All refractory patients remained refractory. From the asymptomatic group, 10.8% became symptomatic (FMTLE). The mean follow up was 76.0 ± 21.2 months. CONCLUSION: Prospective follow up of more than 7 years in patients with FMTLE revealed that it is unlikely to achieve seizure control in those with refractory seizures. Patients with diagnose of more benign forms of FMTLE for more than one year are likely to either remit or remain under well controlled seizures. The majority of patients who had achieved seizure remission remained seizure-free and none became refractory. Asymptomatic individuals had a greater probability to have seizures compared to the general population in a 6 year period of follow up.


2018 ◽  
Vol 115 ◽  
pp. e645-e649
Author(s):  
Yoon Ha Hwang ◽  
Na Young Jung ◽  
Chang Kyu Park ◽  
Won Seok Chang ◽  
Hyun Ho Jung ◽  
...  

2007 ◽  
Vol 29 (6) ◽  
pp. 588-593 ◽  
Author(s):  
Hiroyuki Nakase ◽  
Kentaro Tamura ◽  
Yeong-Jin Kim ◽  
Hidehiro Hirabayashi ◽  
Toshisuke Sakaki ◽  
...  

EP Europace ◽  
2016 ◽  
Vol 18 (suppl_1) ◽  
pp. i12-i12
Author(s):  
Ritsuko Kohno ◽  
Haruhiko Abe ◽  
Naoki Akamatsu ◽  
David G. Benditt

2010 ◽  
Vol 90 (1-2) ◽  
pp. 60-67 ◽  
Author(s):  
Shuli Liang ◽  
Tianxing Liu ◽  
Anmin Li ◽  
Ming Zhao ◽  
Xiaoman Yu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document